Oramed Pharmaceuticals
ORMP
ORMP
103 hedge funds and large institutions have $78.4M invested in Oramed Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 24 closing their positions.
Holders
103
Holders Change
-13
Holders Change %
-11.21%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
34
Reduced
28
Closed
24
Calls
$2.38M
Puts
$928K
Net Calls
+$1.46M
Net Calls Change
-$1.69M
Top Buyers
| 1 |
1
Two Sigma Advisers
New York
|
$5.73M |
| 2 |
2
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$3.33M |
| 3 |
3
BlackRock
New York
|
$15.8M |
| 4 |
4
Morgan Stanley
New York
|
$5.14M |
| 5 |
CSS
5
Cubist Systematic Strategies
Stamford,
Connecticut
|
$2.09M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$3.15M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$1.61M |
| 3 |
3
Renaissance Technologies
New York
|
$0 |
| 4 |
4
D.E. Shaw & Co
New York
|
$119K |
| 5 |
HF
5
HRT Financial
New York
|
$0 |